BioCatalyst

ALECENSA - alectinib hydrochloride capsule — catalyst calendar

1 verified catalyst event(s) referencing ALECENSA - alectinib hydrochloride capsule, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-18
in 2mo
ESTIMATED
 READOUT
Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymo
Phase 2/3 · ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
 Han Xu, M.D., Ph.D., FAPCR, Medica ALECENSA - alectinib hydrochloride capsu ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.